Skip to content
  • ABOUT
  • AUTHOR GUIDELINES
  • AUTHORS/EDITORS
  • SUBSCRIPTIONS
  • CONTACT US
  • MY ACCOUNT
FacebookXLinkedInInstagram
MedWorks Media Logo MedWorks Media Logo MedWorks Media Logo
×
  • HOME
  • PSYCH. BULLETIN
    • LATEST ISSUE
    • BLACK BOOK OF DOSING & MONITORING
  • RATING SCALES
    • LICENSING INFORMATION
  • RESOURCES
    • PSYCHOTROPICS A-Z
    • PSYCHOPHARMACOLOGY 101
  • NEWS
  • Escitalopram Induced SIADH in an Elderly Female: A Case Study1 x $30.00
    Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics1 x $30.00
    Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
    Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study1 x $30.00
    Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression1 x $30.00
    Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder1 x $30.00
    Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting1 x $30.00
    Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain1 x $30.00
    Catatonia and CPK Elevation in Neurosyphilis1 x $30.00
    Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis2 x $30.00
    Antipsychotics Case Study by Yuan-Hwa Chou1 x $30.00
    Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series1 x $30.00
    Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
    Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data1 x $30.00
    View Cart
    Checkout
  • Sort by Date
    • Sort by Name
    • Sort by Price
    • Sort by Date
    • Sort by Popularity
  • Show 20 Products
    • Show 20 Products
    • Show 40 Products
    • Show 60 Products

  • Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder

    $30.00
    Add to cart Details

CONTACT US

58427 Joshua Lane
Yucca Valley CA 92284

‭+1 (917) 692-8000‬
support@medworksmedia.com
MedWorksMedia.com

Privacy Policy
Cookie Policy

Useful Links

About Us

Articles In Press

Author Guidelines

Authors and Editorial Advisors

Journal Supplements

Psychopharmacology 101

Psychopharmacology Bulletin

Psychotropics A-Z

Subscriptions

Recent Psychopharmacology Bulletin Articles

  • Pocket Reference Guide - The Black Book of Psychotropic Dosing and Monitoring - Digital PDF $30.00
  • Trends in Outpatient Buprenorphine Prescribing for Chronic Pain: A Retrospective Analysis Over 18 Months $30.00
  • Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal $30.00

Brain Science Blogs

  • Novel Blood Test Could Help Diagnose and Track Alzheimer’s April 10, 2025
  • New 48-Week Remission Data on Ingrezza for the Treatment of TD April 1, 2025
  • Efficacy of esketamine for perinatal depression January 17, 2025
Copyright 2025 MedWorks Media Inc | All Rights Reserved
FacebookXLinkedInInstagram
Page load link
Go to Top